Six weeks old female NMRI (Naval Medical Research Institute) nude mice were acquired from Taconic Europe (Lille Skensved, Denmark) and allowed to acclimate one week in the animal facility before any intervention was initiated. All experimental procedures were conducted with the guidelines set forth by the Danish Ministry of Justice. Estrogen pellets, 0.72 mg 17-β-Estradiol, 60-day release (Innovative Research of America, Sarasota, FL, USA), were implanted s.c. during anesthesia with 1:1 v/v mixture of Hypnorm® (Janssen Pharmaceutica, Beerse, Belgium) and Dormicum® (Roche, Basel, Switzerland). One week after implantation of pellets, MCF-7 (human breast adenocarcinoma) tumor cells (107 cells in 100 μL medium mixed with 100 μL Matrixgel™ Basement Membrane Matrix (BD Biosciences, San Jose, CA, USA)) were injected subcutaneous into the left and right flank respectively. Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) medium supplemented with 10% fetal calf serum and 1% penicillin-streptomycin in 5% CO2 at 37°C.
>
Chemicals & Drugs
>
Organic Chemical
>
Dormicum
Dormicum
Dormicum is a benzodiazepine medication commonly used as a sedative and hypnotic agent.
It is approved for the management of insomnia, preoperative anxiety, and sedation prior to medical procedures.
Dormicum works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep.
When used as directed, Dormicum can help patients fall asleep faster and sleep more soundly.
Researchers studying the efficacy and safety of Dormicum can utilize PubCompare.ai's AI-driven platform to easily locate relevant protocols from the literature, preprints, and patents, and leverage intelligent comparisons to identify the most accurate and reproducible procedures.
This can enhance research effeciency and accuracy, leading to more robust findings on the clinical applications of Dormicum.
It is approved for the management of insomnia, preoperative anxiety, and sedation prior to medical procedures.
Dormicum works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep.
When used as directed, Dormicum can help patients fall asleep faster and sleep more soundly.
Researchers studying the efficacy and safety of Dormicum can utilize PubCompare.ai's AI-driven platform to easily locate relevant protocols from the literature, preprints, and patents, and leverage intelligent comparisons to identify the most accurate and reproducible procedures.
This can enhance research effeciency and accuracy, leading to more robust findings on the clinical applications of Dormicum.
Most cited protocols related to «Dormicum»
Adenocarcinoma
Anesthesia
Animals
Breast
Cells
Culture Media
Dormicum
Eagle
Estradiol
Estrogens
Females
Fetal Bovine Serum
Homo sapiens
Hypnorm
Magnetic Resonance Imaging
Membrane, Basement
Mice, Nude
Neoplasms
Ovum Implantation
Pellets, Drug
Penicillins
Streptomycin
Studies were conducted with 197 male and female homozygous nude rats (Han:rnu/rnu Rowett) bred and maintained in an isolation facility in a pathogen free environment on a standard 12/12 h day and night cycle. Animals were fed a standard sterilised pellet diet and provided sterile tap water ad libitum. The athymic nude rat is T-cell deficient, but has normal complement and B-cell function [11 (link)]. 10 tumour spheroids (250-350 μm in diameter) were selected under a light microscope. The animals were anaesthetized with Hypnorm-Dormicum (0.4 ml/kg) s.c., the head secured in a stereotactic frame (Benchmark; Neurolab, St Louis, MO) and a short longitudinal incision was made in the scalp exposing the calvarium. A burr-hole was made 1 mm posterior to the bregma and 3 mm to the right of the sagittal suture using a micro-drill with a bit diameter of 2,9 mm. A Hamilton syringe with inner diameter of 810 μm was introduced to a depth of 2, 5 mm below the brain surface, and the spheroids were slowly injected and the syringe left in place for 3 min before withdrawal. The skin was closed with an Ethilon 3-0 suture. The tumours were allowed to grow for 4-5 months, then harvested and passaged onto new animals after initiation of spheroids in vitro. Animals were sacrificed at the onset of symptoms using CO2 and the brains were removed. All procedures and experiments involving animals in this study were approved by The National Animal Research Authority and conducted according to the European Convention for the Protection of Vertebrates Used for Scientific purposes.
Animals
B-Lymphocytes
Brain
Calvaria
Conferences
Diet
Dormicum
Drill
Ethilon
Europeans
Females
Head
Homozygote
Hypnorm
isolation
Light Microscopy
Males
Mice, Nude
Neoplasms
Pathogenicity
Physiology, Cell
Rats, Nude
Reading Frames
Scalp
Skin
Sterility, Reproductive
Sutures
Syringes
T-Lymphocyte
Trephining
Vertebrates
Syrian hamsters (male, 4 weeks old) were purchased from Japan SLC and divided into groups by simple randomization. Baseline body weights were measured before infection. For the virus infection experiments, hamsters were anaesthetized by intramuscular injection of a mixture of 0.15 mg kg−1 medetomidine hydrochloride (Domitor, Nippon Zenyaku Kogyo), 2.0 mg kg−1 midazolam (Dormicum, FUJIFILM Wako Chemicals) and 2.5 mg kg−1 butorphanol (Vetorphale, Meiji Seika Pharma). The B.1.1 virus, Delta, Omicron (10,000 TCID50 in 100 µl) or saline (100 µl) were intranasally inoculated under anaesthesia. Oral swabs were daily collected under anaesthesia with isoflurane (Sumitomo Dainippon Pharma). Body weight, enhanced pause (Penh, see below), the ratio of time to peak expiratory follow relative to the total expiratory time (Rpef, see below) and subcutaneous oxygen saturation (SpO2, see below) were monitored at 1, 3, 5, 7, 10, and 15 d.p.i. Respiratory organs were anatomically collected at 1, 3, 5 and 7 d.p.i. (for lung) or 1, 3 and 7 d.p.i. (for trachea). Viral RNA load in the oral swabs and respiratory tissues was determined by RT–qPCR. Viral titres in the lung hilum were determined by TCID50. These tissues were also used for histopathological and IHC analyses (see below). No method of randomization was used to determine how the animals were allocated to the experimental groups and processed in this study because covariates (sex and age) were identical. The number of investigators was limited, as most of experiments were performed in high-containment laboratories. Therefore, blinding was not carried out.
Anesthesia
Animals
Body Weight
Butorphanol
Dormicum
Exhaling
Hamsters
Herpesvirus 1, Cercopithecine
Infection
Intramuscular Injection
Isoflurane
Lung
Males
Medetomidine Hydrochloride
Mesocricetus auratus
Midazolam
Oxygen Saturation
Pneumonia, Viral
Respiratory Rate
Saline Solution
Saturation of Peripheral Oxygen
Tissues
Trachea
Virus Diseases
Syrian hamsters (male, 4 weeks old) were purchased from Japan SLC. Baseline body weights were measured before infection. For the virus infection experiments in Fig. 2c, d , hamsters were euthanized by intramuscular injection of a mixture of 0.15 mg kg−1 medetomidine hydrochloride (Domitor, Nippon Zenyaku Kogyo), 2.0 mg kg−1 midazolam (Dormicum, Maruishi Pharmaceutical) and 2.5 mg kg−1 butorphanol (Vetorphale, Meiji Seika Pharma). The B.1.1 or B.1.167.2/Delta viruses (105 TCID50 in 100 µl) were intranasally infected under anaesthesia. Body weights were measured, and oral swabs were collected under anaesthesia with isoflurane (Sumitomo Dainippon Pharma) daily. For the virus infection in Fig. 4 , four hamsters per group were intranasally inoculated with the D614G or the D614G/P681R viruses (104 TCID50 in 30 μl) under isoflurane anaesthesia. Body weight was monitored daily for 7 days. For virological examinations, four hamsters per group were intranasally infected with the D614G or the D614G/P681R viruses (104 TCID50 in 30 μl); at 3 and 7 d.p.i., the hamsters were euthanized, and nasal turbinates and lungs were collected. The virus titres in the nasal turbinates and lungs were determined by plaque assays in VeroE6/TMPRSS2 cells.
Anesthesia
Biological Assay
Body Weight
Butorphanol
Cells
Dental Plaque
Dormicum
Hamsters
Herpesvirus 1, Cercopithecine
Infection
Intramuscular Injection
Isoflurane
Lung
Males
Medetomidine Hydrochloride
Mesocricetus auratus
Midazolam
Pharmaceutical Preparations
Physical Examination
TMPRSS2 protein, human
Turbinates
Virus
Virus Diseases
The anesthetic, sedative, and analgesic agents used in the present study were as follows:
ketamine hydrochloride (Ketalar, Sankyo Lifetech Co., Ltd., Tokyo, Japan), xylazine
(Celactar, Bayer Yakuhin Ltd., Tokyo, Japan), pentobarbital sodium (Somnopentyl, Kyoritsu
Seiyaku Co., Ltd.), medetomidine hydrochloride (Domitol, Meiji Seika Pharma Co., Ltd.,
Tokyo, Japan), midazolam (Dormicum, Astellas Pharma Inc., Tokyo, Japan), butorphanol
(Vetorphale, Meiji Seika Pharma Co., Ltd.), and isoflurane (Isoflu, DS Pharma Animal
Health Co., Ltd., Osaka, Japan). All agents were kept at room temperature before use.
Animals were divided into four groups corresponding to each anesthetic protocol as
follows: ketamine hydrochloride and xylazine combined (K/X; ketamine hydrochloride 100
mg/kg and xylazine 10 mg/kg); pentobarbital monoanesthesia (50 mg/kg); medetomidine,
midazolam, and butorphanol combined (M/M/B; medetomidine 0.3 mg/kg, midazolam 4 mg/kg, and
butorphanol 5 mg/kg); and inhalant anesthesia using isoflurane (5% for induction and 2%
for maintenance). In the M/M/B group, mice were administered atipamezole (Antisedan,
Zoetis Japan Inc., Tokyo, Japan) at a dose of 0.3 mg/kg 30 min after the administration of
M/M/B. All injectable anesthetics were administered intraperitoneally. The dose and
concentration of each agent were as reported previously in mice [4 (link), 5 (link), 17 (link)]. Before administration, the concentration of M/M/B, K/X, and
pentobarbital sodium was adjusted to 6 ml/kg by diluting with saline. In the M/M/B
anesthetic group, a mixture of medetomidine, midazolam, and butorphanol with saline was
prepared and then concurrently administered. Similarly, the mixture of ketamine
hydrochloride and xylazine was adjusted with saline before concurrent administration.
Isoflurane anesthesia was administered using a commercially available rodent inhalant
anesthesia apparatus (SomnoSuite Small Animal Anesthesia System, Kent Scientific
Corporation), which has a digital vaporizer and internal air-flow pump. The vaporized
anesthetic gas was introduced into the induction chamber and nose mask (Kent Scientific
Corporation) at a flow rate of 32 ml/min. The nose mask was covered with a latex membrane
that had a hole in the center to fit closely around the nose. Initially, mice were induced
with isoflurane at a 5% concentration. Once loss of the postural reaction and righting
reflex was confirmed, the mice were rapidly transferred to the nose mask, and anesthesia
was maintained with 2% isoflurane (Fig. 1 ![]()
).
ketamine hydrochloride (Ketalar, Sankyo Lifetech Co., Ltd., Tokyo, Japan), xylazine
(Celactar, Bayer Yakuhin Ltd., Tokyo, Japan), pentobarbital sodium (Somnopentyl, Kyoritsu
Seiyaku Co., Ltd.), medetomidine hydrochloride (Domitol, Meiji Seika Pharma Co., Ltd.,
Tokyo, Japan), midazolam (Dormicum, Astellas Pharma Inc., Tokyo, Japan), butorphanol
(Vetorphale, Meiji Seika Pharma Co., Ltd.), and isoflurane (Isoflu, DS Pharma Animal
Health Co., Ltd., Osaka, Japan). All agents were kept at room temperature before use.
Animals were divided into four groups corresponding to each anesthetic protocol as
follows: ketamine hydrochloride and xylazine combined (K/X; ketamine hydrochloride 100
mg/kg and xylazine 10 mg/kg); pentobarbital monoanesthesia (50 mg/kg); medetomidine,
midazolam, and butorphanol combined (M/M/B; medetomidine 0.3 mg/kg, midazolam 4 mg/kg, and
butorphanol 5 mg/kg); and inhalant anesthesia using isoflurane (5% for induction and 2%
for maintenance). In the M/M/B group, mice were administered atipamezole (Antisedan,
Zoetis Japan Inc., Tokyo, Japan) at a dose of 0.3 mg/kg 30 min after the administration of
M/M/B. All injectable anesthetics were administered intraperitoneally. The dose and
concentration of each agent were as reported previously in mice [4 (link), 5 (link), 17 (link)]. Before administration, the concentration of M/M/B, K/X, and
pentobarbital sodium was adjusted to 6 ml/kg by diluting with saline. In the M/M/B
anesthetic group, a mixture of medetomidine, midazolam, and butorphanol with saline was
prepared and then concurrently administered. Similarly, the mixture of ketamine
hydrochloride and xylazine was adjusted with saline before concurrent administration.
Isoflurane anesthesia was administered using a commercially available rodent inhalant
anesthesia apparatus (SomnoSuite Small Animal Anesthesia System, Kent Scientific
Corporation), which has a digital vaporizer and internal air-flow pump. The vaporized
anesthetic gas was introduced into the induction chamber and nose mask (Kent Scientific
Corporation) at a flow rate of 32 ml/min. The nose mask was covered with a latex membrane
that had a hole in the center to fit closely around the nose. Initially, mice were induced
with isoflurane at a 5% concentration. Once loss of the postural reaction and righting
reflex was confirmed, the mice were rapidly transferred to the nose mask, and anesthesia
was maintained with 2% isoflurane (
Vital signs monitoring during isoflurane anesthesia in mice. The rectal probe and
pulse oximeter are located at the colorectum and tail base, respectively.
Analgesics
Anesthesia
Anesthetics
Animals
atipamezole
Butorphanol
Dormicum
Fingers
Inhalation Drug Administration
Isoflurane
Ketalar
Ketamine Hydrochloride
Latex
Medetomidine
Medetomidine Hydrochloride
Mice, House
Midazolam
Nose
Pentobarbital
Pentobarbital Sodium
Rectum
Rodent
Saline Solution
Sedatives
Signs, Vital
Sodium
Tail
Vaporizers
Xylazine
Most recents protocols related to «Dormicum»
BN rats were anesthetised on Day 53 by injection of hypnorm-dormicum and initial ear thickness was measured twice. Subsequently, an EST was performed by intradermally injecting 10 µg of PPE in 20 µL PBS into right ear of each rat as previously described (34 (link)). Ear thickness was measured again 30 min after the injection and ear swelling was determined as a measure of the clinical relevance of the peanut sensitisation.
Arachis hypogaea
Dormicum
Hypnorm
Rats, Inbred BN
The maxillary molars were extracted under anesthesia with triple anesthesia (medetomidine hydrochloride 0.75 mg/kg (Domitol, Nippon Zenyaku Kogyo Co.,Ltd. Fukushima, Japan), midazolam 4.0 mg/kg (Dormicum, Sandoz K. K., Tokyo, Japan), butorphanol 5.0 mg/kg (Vetorphale, Meiji Seika Pharma Co., Ltd. Tokyo, Japan)) using hooked-end forceps. After surgery, mice were injected with Atipamezole 0.75 mg/kg (antisedan, Nippon Zenyaku Kogyo Co.,Ltd.) to antagonize the anesthesia effect. Two weeks later, the tissue from the extraction socket was collected and used for analysis.
Anesthesia
Anesthetic Effect
atipamezole
Butorphanol
Dormicum
Forceps
Gomphosis
Maxilla
Medetomidine Hydrochloride
Mice, House
Midazolam
Molar
Operative Surgical Procedures
Tissues
Mice in the pBOO study were implanted with a catheter, and mice in the SCI study were implanted with a catheter and EUS-EMG electrodes. The implantation surgery was performed as previously described [20 (link)]. Briefly, mice were anesthetized with a mixture of medetomidine (0.5 mg/kg, Domitor, Orion Corporation, Espoo, Finland), midazolam (5 mg/kg, Dormicum® Midazolamum 5 mg/mL, Roche Pharma (Schweiz) AG, Reinach, Switzerland), and fentanyl (50 µg/kg, Fentanyl Sintetica, Sintetica S.A., Mendrisio, Switzerland) injected subcutaneously, and midline laparotomy performed to expose the bladder. A catheter with a flared end (Intravascular PE-10 tubing, SAI Infusion Technologies, Lake Villa, Illinois, USA) was implanted into the bladder dome with a purse string suture (6-0 PROLENE®, 8807H, Ethicon, Somerville, NJ, USA) and tunneled subcutaneously to the neck of the animal, externalized, and fixed to an infusion harness (SMH, SAI Infusion Technologies, Lake Villa, IL, USA). The animal wore the harness throughout the experiment. In the SCI study, mice additionally were implanted with two electrodes affixed on either side of the EUS to the lateral fat tissue and one ground electrode to the abdominal muscle. The electrodes were tunneled subcutaneously into the animal’s neck, exteriorized, soldered to a connector (850-10-050-10-001101, Preci-Dip, Delémont, Switzerland), and affixed to the harness. Daily assessments of bodyweight, physical appearance (mobility, bite wounds), and signs of pain served to monitor the animal’s health.
Abdominal Muscles
Animals
Bites
Body Weight
Catheters
Dormicum
Fentanyl
Laparotomy
Medetomidine
Mice, House
Midazolam
Neck
Operative Surgical Procedures
Ovum Implantation
Pain
Physical Appearance, Body
Prolene
Range of Motion, Articular
Sutures
Tissue, Adipose
Urinary Bladder
Mice were anesthetized using a mixture of three drugs: 0.75 mg/kg body weight (b.w.) medetomidine (Domitor, Nippon Zenyaku Kogyo Co., Ltd., Tokyo, Japan), 4.0 mg/kg b.w. midazolam (Dormicum, Astellas Pharma Inc., Tokyo, Japan), and 5.0 mg/kg b.w. butorphanol (Vetorphale, Meiji Seika Kaisha, Ltd., Tokyo, Japan). These drugs were diluted in sterile saline to 0.1 ml/10 g b.w./mouse and were administered through intraperitoneal injection. HA and collagen constructs that differentiated in the hypertrophic medium for 2 weeks were implanted subcutaneously into the back of nude mice. Briefly, two subcutaneous pockets were created along the central line of the spine in each mouse, and two to three constructs were inserted into each pocket (n = 5). In some experiments, to prevent hyaluronan constructs from fusing, four pockets were created in both lateral sites of the spine, two at the shoulders and two at the hips; one hyaluronan construct was inserted into each pocket (4 constructs/mouse). After suturing the surgical sites, mice were injected with an antagonist: 0.75 mg/kg b.w. atipamezole (Antisedan; Nippon Zenyaku Kogyo Co., Ltd.). The animals were monitored every couple of days during the healing period for any possible complications. The number of experimental samples was determined based on earlier reports [10 (link)–14 (link), 17 (link), 18 (link)]. Mice of the same age were randomly selected and assigned to each implantation group. A total of 23 mice were used in the in vivo transplantation studies, including preliminary studies to determine the optimal amount of hydrogel and the number of MSCs.
The mice were euthanazed by carbon dioxide inhalation with little suffering at 4 and 8 weeks post-implantation, and the constructs were collected for analysis.
The mice were euthanazed by carbon dioxide inhalation with little suffering at 4 and 8 weeks post-implantation, and the constructs were collected for analysis.
Animals
atipamezole
Body Weight
Butorphanol
Carbon dioxide
Collagen
Coxa
Dormicum
Hyaluronic acid
Hypertrophy
Inhalation
Injections, Intraperitoneal
Medetomidine
Mice, House
Mice, Nude
Midazolam
Operative Surgical Procedures
Ovum Implantation
PEGDMA Hydrogel
Pharmaceutical Preparations
Saline Solution
Shoulder
Sterility, Reproductive
Transplantation
Venous Catheter, Central
Vertebral Column
This prospective cross-sectional study was carried out from October 2017 to April 2019, enrolling 100 neonates admitted to the neonatal intensive care unit (NICU) of the Children’s Hospital of Ain Shams University, Cairo, Egypt. Inclusion criteria were neonates with a gestational age ≥28 weeks who were suffering from respiratory distress disorders; exclusion criteria were neonates having multiple congenital anomalies, chromosomal aberrations, hydrops fetalis and/or heart failure. Expert neonatologists managed enrolled neonates according to the NICU protocol [7 ].
Downes and Silverman–Andersen clinical scores were applied to evaluate neonatal respiratory distress severity. The Silverman–Anderson score was ideally used for preterm infants, and the Downes score was used for term infants [8 (link),9 (link),10 (link)].
Plain CXR and LUS were done on admission for diagnosis and were repeated after 7 days, or if needed earlier within the 7 days, by the treating neonatologist in parallel to the clinical assessment and laboratory findings to diagnose the cause of respiratory distress. CXR images were posterior–anterior view, using the digital GE (General Electric) Optima XR220 AMX pro series X-ray machine, (GE HealthCare, Chicago, IL, USA).
CXR findings were interpreted and used as the gold standard to diagnose and differentiate variable etiologies of neonatal respiratory distress: transient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), neonatal pneumonia, meconium aspiration syndrome (MAS), pulmonary interstitial emphysema (PIE), pneumothorax (PTX), pleural effusion (PE), pulmonary atelectasis (PA) and congenital diaphragmatic hernia (CDH) [1 (link),2 (link),11 ,12 (link),13 ,14 (link),15 ,16 (link)].
Lung ultrasound (LUS) examination was done using the GE Logiq 400 pro series ultrasound machine, with a linear 8 MHz microprobe, (GE HealthCare, Chicago, IL, USA). LUS was performed by a single radiology consultant. The neonatologists were blind to lung ultrasound diagnoses. Neonates were examined lying in a supine position and in a resting state with the surrounding light intensity kept constant and low; as the phototherapy device was turned off if it was on. Gentle handling, including quiet voice tones and fine touching, was applied to avoid stressful situations or cause for crying. In order to pacify babies on continuous positive airway pressure (CPAP) or nasal cannula, oral dextrose drops or a pacifier were given, and stimulation of non-nutritional sucking was applied, while others on ventilation might have been sedated by intravenous Dormicum.
During the study, LUS examination was done using the following LUS score: every lung was divided into 3 areas (upper anterior, lower anterior and lateral) and a linear microprobe was used in lung examination through both transverse and longitudinal scans. For every lung area, a point score from 0 to 3 was applied (total score varying from 0 to 18). The LUS score was allocated as follows:
0: Denotes A-pattern (defined by the existence of the A-lines only, which emerges from the pleural line reverberation artifact);
1: B-pattern (defined by the existence of ≥3 well-spaced B-lines; B-lines are lines reaching the screen edge in the absence of fading);
2: Severe B-pattern (defined by the existence of coalescent and crowded B-lines with or without consolidations restricted to the subpleural space);
3: Extended consolidations.
A-lines denote pleural reflection because of ultrasound diffusing through an air-filled lung; B-lines denote fluid filling the interstitium (and the alveolar space if they become coalescent). LUS diagnostic criteria for neonatal respiratory diseases were according to Corsini et al. [17 (link),18 (link)].
Downes and Silverman–Andersen clinical scores were applied to evaluate neonatal respiratory distress severity. The Silverman–Anderson score was ideally used for preterm infants, and the Downes score was used for term infants [8 (link),9 (link),10 (link)].
Plain CXR and LUS were done on admission for diagnosis and were repeated after 7 days, or if needed earlier within the 7 days, by the treating neonatologist in parallel to the clinical assessment and laboratory findings to diagnose the cause of respiratory distress. CXR images were posterior–anterior view, using the digital GE (General Electric) Optima XR220 AMX pro series X-ray machine, (GE HealthCare, Chicago, IL, USA).
CXR findings were interpreted and used as the gold standard to diagnose and differentiate variable etiologies of neonatal respiratory distress: transient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), neonatal pneumonia, meconium aspiration syndrome (MAS), pulmonary interstitial emphysema (PIE), pneumothorax (PTX), pleural effusion (PE), pulmonary atelectasis (PA) and congenital diaphragmatic hernia (CDH) [1 (link),2 (link),11 ,12 (link),13 ,14 (link),15 ,16 (link)].
Lung ultrasound (LUS) examination was done using the GE Logiq 400 pro series ultrasound machine, with a linear 8 MHz microprobe, (GE HealthCare, Chicago, IL, USA). LUS was performed by a single radiology consultant. The neonatologists were blind to lung ultrasound diagnoses. Neonates were examined lying in a supine position and in a resting state with the surrounding light intensity kept constant and low; as the phototherapy device was turned off if it was on. Gentle handling, including quiet voice tones and fine touching, was applied to avoid stressful situations or cause for crying. In order to pacify babies on continuous positive airway pressure (CPAP) or nasal cannula, oral dextrose drops or a pacifier were given, and stimulation of non-nutritional sucking was applied, while others on ventilation might have been sedated by intravenous Dormicum.
During the study, LUS examination was done using the following LUS score: every lung was divided into 3 areas (upper anterior, lower anterior and lateral) and a linear microprobe was used in lung examination through both transverse and longitudinal scans. For every lung area, a point score from 0 to 3 was applied (total score varying from 0 to 18). The LUS score was allocated as follows:
0: Denotes A-pattern (defined by the existence of the A-lines only, which emerges from the pleural line reverberation artifact);
1: B-pattern (defined by the existence of ≥3 well-spaced B-lines; B-lines are lines reaching the screen edge in the absence of fading);
2: Severe B-pattern (defined by the existence of coalescent and crowded B-lines with or without consolidations restricted to the subpleural space);
3: Extended consolidations.
A-lines denote pleural reflection because of ultrasound diffusing through an air-filled lung; B-lines denote fluid filling the interstitium (and the alveolar space if they become coalescent). LUS diagnostic criteria for neonatal respiratory diseases were according to Corsini et al. [17 (link),18 (link)].
Atelectasis
Blindness
Child
Chromosome Aberrations
Congestive Heart Failure
Consultant
Continuous Positive Airway Pressure
Diagnosis
Dormicum
Electricity
Gestational Age
Glucose
Gold
Hernia, Congenital Diaphragmatic
Hydrops Fetalis
Infant
Infant, Newborn
Light
Lung
Lung Diseases
Meconium Aspiration Syndrome
Medical Devices
Multiple Abnormalities
Nasal Cannula
Neonatal Diseases
Neonatologists
Pacifiers
Phototherapy
Pleura
Pleural Effusion
Pneumonia
Pneumothorax
Preterm Infant
Pulmonary Emphysema
Radiography
Radionuclide Imaging
Reflex
Respiration Disorders
Respiratory Distress Syndrome
Respiratory Rate
salicylhydroxamic acid
Transient Tachypnea of the Newborn
Ultrasonography
X-Rays, Diagnostic
Top products related to «Dormicum»
Sourced in Switzerland, Belgium, United Kingdom, Germany, France, Japan, Sweden, United States, Turkiye
Dormicum is a drug used as a sedative and anesthetic in various medical procedures. It contains the active ingredient midazolam, which is a benzodiazepine medication. Dormicum is administered intravenously or intramuscularly by healthcare professionals to induce sedation or anesthesia.
Sourced in Japan
Vetorphale is a laboratory equipment designed for the separation and analysis of peptides and proteins. It utilizes a specialized chromatography technique to isolate and purify these biomolecules from complex samples. The core function of Vetorphale is to provide researchers and scientists with a reliable and efficient tool for the study of peptides and proteins, which are essential components in various biological and pharmaceutical applications.
Sourced in Japan, Finland
Dormicum is a benzodiazepine medication primarily used as a sedative and hypnotic. It is a prescription drug indicated for the short-term treatment of insomnia. Dormicum works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain, to promote relaxation and sleep. The product is available in various dosage forms, including tablets and oral solution.
Sourced in Japan
Domitor is a sedative and analgesic agent used in veterinary medicine. It is designed to induce a state of calm and reduced sensitivity to pain in animals.
Sourced in Finland, Germany, United Kingdom, Sweden, Japan, Australia, United States
Domitor is a pharmaceutical product used for veterinary purposes. It is a sedative and analgesic agent that provides a safe and effective method for sedating and immobilizing animals. The core function of Domitor is to induce a state of calm and relaxation in animals, allowing for various medical procedures and treatments to be performed safely and with minimal distress to the animal.
Sourced in Belgium, United Kingdom
Hypnorm is a laboratory equipment product manufactured by Johnson & Johnson. It is designed to provide a stable and controlled environment for conducting various experiments and research activities.
Sourced in Japan
Domitol is a laboratory equipment used for the isolation and purification of chemical compounds. It is designed to efficiently separate and collect target compounds from complex mixtures through a process of differential solubility.
Sourced in Japan
Antisedan is a laboratory equipment product manufactured by Nippon Zenyaku Kogyo. It is designed to serve as an antagonist, reversing the effects of sedative drugs.
Sourced in Germany, Switzerland
Anexate is a medical device used in clinical laboratories. It serves as a diagnostic tool for the detection and analysis of various analytes in biological samples.
Sourced in Germany, Finland, Belgium, United States
Fentanyl is a synthetic opioid that is used as a pharmaceutical product in medical settings. It is a potent analgesic that is primarily used to manage severe pain in patients, particularly those with cancer or other chronic pain conditions. Fentanyl is available in various forms, including transdermal patches, lozenges, and injectable solutions. The product is intended for use under the supervision of healthcare professionals, as it carries significant risks of abuse and overdose.
More about "Dormicum"
Dormicum, a benzodiazepine medication commonly used as a sedative and hypnotic agent, is approved for the management of insomnia, preoperative anxiety, and sedation prior to medical procedures.
This medication works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep.
When used as directed, Dormicum can help patients fall asleep faster and sleep more soundly.
Researchers studying the efficacy and safety of Dormicum can utilize PubCompare.ai's AI-driven platform to easily locate relevant protocols from the literature, preprints, and patents, and leverage intelligent comparisons to identify the most accurate and reproducible procedures.
This can enhance research efficiency and accuracy, leading to more robust findings on the clinical applications of Dormicum.
In addition to Dormicum, other related sedative and hypnotic medications include Vetorphale, Domitor, Hypnorm, Domitol, Antisedan, Anexate, and Fentanyl.
These medications may have similar mechanisms of action and clinical applications, but it's important to consult with a healthcare professional to determine the most appropriate treatment option.
By incorporating synonyms, related terms, abbreviations, and key subtopics, researchers can optimize their Dormicum research and leverage the power of PubCompare.ai's platform to enhance the efficiency and accuracy of their studies.
This can lead to more robust findings and a better understanding of the clinical applications of this important medication.
This medication works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep.
When used as directed, Dormicum can help patients fall asleep faster and sleep more soundly.
Researchers studying the efficacy and safety of Dormicum can utilize PubCompare.ai's AI-driven platform to easily locate relevant protocols from the literature, preprints, and patents, and leverage intelligent comparisons to identify the most accurate and reproducible procedures.
This can enhance research efficiency and accuracy, leading to more robust findings on the clinical applications of Dormicum.
In addition to Dormicum, other related sedative and hypnotic medications include Vetorphale, Domitor, Hypnorm, Domitol, Antisedan, Anexate, and Fentanyl.
These medications may have similar mechanisms of action and clinical applications, but it's important to consult with a healthcare professional to determine the most appropriate treatment option.
By incorporating synonyms, related terms, abbreviations, and key subtopics, researchers can optimize their Dormicum research and leverage the power of PubCompare.ai's platform to enhance the efficiency and accuracy of their studies.
This can lead to more robust findings and a better understanding of the clinical applications of this important medication.